Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-05-19

FDA Approved: CAPTOPRIL — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for captopril submitted by Solco Healthcare US, LLC, updating the labeling for the generic drug captopril.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAPTOPRIL (Captopril)

Snippet

SUPPL AP for CAPTOPRIL (CAPTOPRIL)